InoRx appoints Avi Kulkarni as Chief Executive Officer, Head of CRO, marking an important leadership addition as it continues to strengthen its digital and technology capabilities. In his new role, Avi will lead the executive function, driving clinical research initiatives, strengthening research and development platforms, and enabling scalable, secure, and future-ready operations aligned with business objectives across the healthcare and life sciences sector.

The appointment reflects the firm’s focus on leveraging technology as a key enabler of operational excellence, efficiency, and innovation. Avi will play a critical role in spearheading pharmaceutical strategy, enhancing digital resilience, and supporting cross-functional teams with robust technology solutions across the global enterprise.

Avi brings extensive leadership experience from organizations including Cognizant, Wipro, and Accenture. His journey positions the group to accelerate its digital journey and build a strong foundation for long-term organizational success.

CXO TechBOT wishes Avi Kulkarni great success in his new role at InoRx.